Shows the Federal medical-biological Agency of Russia the drug from coronavirus "Mefloquine" it is easy to carry and has a strong protivomigrenosny action, said the head of the FMBA Veronika Skvortsova. "Mefloquine" and hcl - labeled analogues of drugs of quinine against malaria, but significantly less toxicity, easy portable and with a very pronounced protivomigrenosny action, that is, in the determination of (ten millimole per liter) of the drug causes complete inhibition of cytopathic effects in tissue culture ", - said Skvortsova in the program "Evening with Vladimir Solovyov" on TV channel " Russia 1 ". She noted that the Agency conducts research on drug in collaboration with the Institute of Microbiology of the Ministry of defense. the Federal medical-biological Agency there are about three thousand packages of "Mefloquine" to enable clinical trials, said Skvortsova. FMBA is ready to give the drug to the hospital in Kommunarka. The head of the Agency said that the drug has the ability to be effective not only for treatment but also for prevention. "If this is confirmed in clinical trials, then we will have an effective remedy ", - said Skvortsova. FMBA first developed the treatment of coronavirus infection on the basis of the antimalarial drug " Mefloquine ". Pandemic COVID-19, announced on March eleven, covered 177 countries. The first cases were recorded in the Chinese city of Wuhan at the end of last year. According to who, the world found more than 690 thousand cases of infection, more than 33 thousand people died. Difficult situation with coronavirus emerging in the United States, Italy, Spain and several European countries. In China, where it began to spread COVID-19, yesterday told of stopping the epidemic. in Russia at the moment was 1836 patients with coronavirus (1226 of them in Moscow), 66 patients were cured. The latest information on the situation of COVID-19 in Russia and the world presented on the portal stopmanager. Of the Russian Federation. <span style="color:darkgray